Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of metformin/ursolic acid nano oral preparation and preparation method thereof

A technology of metformin and oral preparations, which is applied in the direction of pharmaceutical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., which can solve problems such as increased liver burden, increased nephrotoxicity, and increased lactic acid, so as to improve biological Utilization, reduced gastrointestinal irritation, long-lasting release

Inactive Publication Date: 2021-05-18
FUZHOU UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the most common side effect of metformin is that it will irritate the digestive tract when it first enters the human body, causing nausea, vomiting, bloating and other discomfort symptoms. At the same time, taking metformin will lead to increased lactic acid and increase the burden on the liver
In addition, metformin can only be eliminated by the kidneys in the body, which also increases nephrotoxicity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of metformin/ursolic acid nano oral preparation and preparation method thereof
  • A kind of metformin/ursolic acid nano oral preparation and preparation method thereof
  • A kind of metformin/ursolic acid nano oral preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] 1) Weigh 33 mg of metformin hydrochloride, dissolve it in 20 mL of distilled water, and make it into an aqueous solution of metformin hydrochloride; weigh 46.5 mg of ursolic acid powder, dissolve it in 5 mL of methanol, and make it into an ursolic acid solution;

[0034] 2) Add 20mL of metformin hydrochloride aqueous solution into a 100mL small beaker, then slowly add 1mL of ursolic acid solution dropwise to it, and stir at room temperature for 1 hour to make it self-assemble to form a metformin / ursolic acid nanoparticle solution;

[0035] 3) Take polyethylene glycol and water to prepare 150ml of 0.1mg / ml polyethylene glycol aqueous solution; mix the obtained metformin / ursolic acid nanoparticle solution with polyethylene glycol aqueous solution and freeze-dry to obtain the drug-containing powder ;

[0036] 4) Add 60 mg of lactose, 15 mg of croscarmellose sodium, 5 mg of silicon dioxide, 5 mg of magnesium stearate and 5 mg of talc into the obtained drug-containing powder...

Embodiment 2

[0038] 1) Weigh 33 mg of metformin hydrochloride, dissolve it in 20 mL of distilled water, and make it into an aqueous solution of metformin hydrochloride; weigh 46.5 mg of ursolic acid powder, dissolve it in 5 mL of methanol, and make it into an ursolic acid solution;

[0039] 2) Add 20mL of metformin hydrochloride aqueous solution into a 100mL small beaker, then slowly add 1mL of ursolic acid solution dropwise to it, and stir at room temperature for 1 hour to make it self-assemble to form a metformin / ursolic acid nanoparticle solution;

[0040] 3) Take polyvinylpyrrolidone and water to form 150ml of 0.1mg / ml polyvinylpyrrolidone aqueous solution; mix the obtained metformin / ursolic acid nanoparticle solution with polyvinylpyrrolidone aqueous solution and freeze-dry to obtain the drug-containing powder;

[0041] 4) Add 60 mg of lactose, 15 mg of crospovidone, 10 mg of silicon dioxide and 5 mg of talc to the obtained drug-containing powder, and mix evenly to obtain the metformin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a metformin / ursolic acid nanometer oral preparation and a preparation method thereof, which uses self-assembly nanotechnology to self-assemble metformin and pentacyclic triterpenoid natural product ursolic acid into a particle size of 180-220 nm left and right nanoparticles, and together with the main auxiliary materials, additional auxiliary materials, and stabilizers to make nano oral preparations, the nano oral preparations obtained in the present invention have the effect of sustained release, and can reduce the side effects caused by common oral metformin hydrochloride preparations.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a metformin / ursolic acid nanometer oral preparation and a preparation method thereof. Background technique [0002] Ursolic acid is a pentacyclic triterpenoid compound that exists in natural plants. It has various biological effects such as sedation, anti-inflammatory, antibacterial, anti-diabetic, anti-ulcer, and lowering blood sugar. Ursolic acid also has obvious anti-inflammatory effects. Oxidative function, thus widely used as medicine and cosmetic raw materials. [0003] Metformin is a biguanide oral hypoglycemic agent, and it is the first choice for type 2 diabetes that is ineffective in simple diet control and physical exercise, especially obese type 2 diabetes. Metformin has a variety of hypoglycemic mechanisms, including delaying the uptake of glucose from the gastrointestinal tract, increasing the utilization of peripheral glucose by imp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/00A61K47/10A61K47/32A61K47/38A61K47/36A61K47/02A61K31/56A61K31/155A61P3/10
CPCA61K9/0053A61K31/155A61K31/56A61K47/02A61K47/10A61K47/32A61K47/36A61K47/38A61K2300/00
Inventor 邵敬伟林娟芳郭燕
Owner FUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com